Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) Short Interest Update

Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) was the recipient of a large decrease in short interest in July. As of July 15th, there was short interest totaling 4,306 shares, a decrease of 85.6% from the June 30th total of 29,843 shares. Approximately 0.4% of the shares of the stock are sold short. Based on an average daily trading volume, of 11,693 shares, the days-to-cover ratio is presently 0.4 days.

Institutional Investors Weigh In On Virtus LifeSci Biotech Products ETF

Several institutional investors have recently bought and sold shares of the company. Flow Traders U.S. LLC acquired a new position in shares of Virtus LifeSci Biotech Products ETF during the second quarter worth $431,000. Prime Capital Investment Advisors LLC purchased a new position in Virtus LifeSci Biotech Products ETF during the 4th quarter worth $1,896,000. Finally, Comprehensive Financial Planning Inc. PA purchased a new position in Virtus LifeSci Biotech Products ETF during the 4th quarter worth $557,000.

Virtus LifeSci Biotech Products ETF Stock Down 0.9%

Shares of NYSEARCA:BBP traded down $0.87 during trading on Friday, reaching $96.39. The company’s stock had a trading volume of 1,927 shares, compared to its average volume of 8,109. The firm’s 50 day simple moving average is $91.90 and its two-hundred day simple moving average is $86.41. Virtus LifeSci Biotech Products ETF has a 12 month low of $60.91 and a 12 month high of $105.21.

About Virtus LifeSci Biotech Products ETF

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.